Top Story

Scientists develop hand-held DNA sequencer for infectious diseases

August 30, 2014

New Zealand researchers have developed a novel, hand-held DNA assay capable of detecting suspected viruses and bacteria, as well as the severity of infection, according to a news release.

The battery-powered device, which utilizes quantitative PCR technology, provides results within 1 hour, potentially allowing its user to determine the presence of a pathogen and the extent of infection in samples while remaining at the site of an outbreak.

In the Journals

S-1 noninferior to UFT/LV for stage III colon cancer

August 29, 2014
Adjuvant chemotherapy with the oral fluoropyrimidine derivative S-1 conferred similar DFS rates as tegafur-uracil plus leucovorin among patients with stage III

Survey shows doctors predominantly lead ACOs

August 29, 2014
Accountable Care Organizations are largely led by physicians or physician and hospital partnerships, according to data published in Health Affairs. “The broad…
In the Journals

GERD patients did not adhere to recommended dietary guidelines

August 29, 2014
Patients with gastroesophageal reflux disease were as or more likely to consume reflux-triggering foods than controls, according to new research data.To determine if…
More News Headlines »

HCV Consults: Volume 1, Number 2

This activity is supported by educational grants from AbbVie and Genentech.

Approved interferon-free therapy has already become entrenched among clinicians for patients with HCV genotypes 2 and…
More »
Meeting News Coverage Video

High SVR rates met among HCV patients in ION-2

May 15, 2014
CHICAGO — HCV Next Editorial Board member Paul Y. Kwo, MD, professor of medicine and director of…
More »

Rapid Response from London 2014: Evaluating Emerging IFN-Free Treatment Regimens for HCV

This activity is supported by an educational grant from AbbVie.

Chronic hepatitis C virus (HCV) infection is a leading cause of cirrhosis, end-stage liver disease, hepatocellular…
More »